Atrial fibrillation and the risk of death in patients with heart failure: A literature-based meta-analysis

Internal Medicine Journal

Volumn 40, Issue 5, 2010, Pages 347-356

  Wasywich, C A ^a   Pope, A J ^b   Somaratne, J ^b   Poppe, K K ^b   Whalley, G A ^b   Doughty, R N ^b  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Atrial fibrillation; Heart failure; Meta analysis; Prognosis

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DEATH; EMBASE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART FAILURE; HEART RHYTHM; HEART VENTRICLE FAILURE; HOSPITALIZATION; HUMAN; MEDICAL LITERATURE; MEDLINE; META ANALYSIS; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK; SINUS RHYTHM; SYSTEMATIC REVIEW;

ATRIAL FIBRILLATION; HEART FAILURE; HUMANS; MORTALITY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS;

EID: 77952685816     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2009.01991.x     Document Type: Article

References (54)

1. Mclean AS, Eslick GD, Coats AJS. The epidemiology of heart failure in Australia. Int J Cardiol 2007 118: 370-374.
2. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart 2007 93: 1137-1146.
3. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1988 98: 946-952.
4. Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol 2003 91: 2-8.
5. Nattel S. Ionic determinants of atrial fibrillation and Ca2+ channel abnormalities: cause, consequence, or innocent bystander? Circ Res 1999 85: 473-476.
6. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995 92: 1954-1968.
7. Amir O, Amir RE, Paz H, Mor R, Sagiv M, Lewis BS. Aldosterone synthase gene polymorphism as a determinant of atrial fibrillation in patients with heart failure. Am J Cardiol 2008 102: 326-329.
8. Pozzoli M, Cioffi G, Traversi E, Pinna GD, Cobelli F, Tavazzi L. Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm. J Am Coll Cardiol 1998 32: 197-204.
9. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986 7: 177-188.
10. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003 327: 557-560.
11. Cochran W. The combination of estimates from different experiments. Biometrics 1954 10: 101-129.
12. Light R, Pillemer D. Summing up: The Science of Reviewing Research.
13. The Cochran Collaboration. RevMan Analyses. Review Manager (RevMan) 42. Version 1.0 for Windows ed.
14. Hayden JA, Cote P, Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med 2006 144: 427-437.
15. Ahmed A, Perry GJ. Incident atrial fibrillation and mortality in older adults with heart failure. Eur J Heart Fail 2005 7: 1118-1121. (Pubitemid 41721113) (Pubitemid 41721113)
16. Middlekauff HR, Stevenson WG, Stevenson LW. Prognostic significance of atrial fibrillation in advanced heart failure. Circulation 1991 84: 40-8.
17. Shamagian LG, Roman AV, Seara JG, Sande JLM, Veloso PR, Gonzalez-Juanatey Jr. Atrial fibrillation in patients hospitalized for congestive heart failure: the same prognostic influence independently of left ventricular systolic function? Int J Cardiol 2006 110: 366-372.
18. Rockman HA, Juneau C, Chatterjee K, Rouleau JL. Long-term predictors of sudden and low output death in chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol 1989 64: 1344-1348.
19. Lengyel M, Kokeny M. Follow-up study in congestive (dilated) cardiomyopathy. Acta Cardiol 1981 36: 35-48.
20. Dias P, Rodrigues RA, Queiros MC, Monteiro E, Pimenta J, Frioes F et al. Prognosis in patients with heart failure and preserved left ventricular systolic function. Rev Port Cardiol 2001 20: 1223-1232.
21. Corell P, Gustafsson F, Schou M, Markenvard J, Nielsen T, Hildebrandt P. Prevalence and prognostic significance of atrial fibrillation in outpatients with heart failure due to left ventricular systolic dysfunction. Eur J Heart Fail 2007 9: 258-265.
22. Wojtkowska I, Sobkowicz B, Musial WJ, Kozuch M. Persistent atrial fibrillation as a prognostic factor of outcome in patients with advanced heart failure. Kardiol Pol 2006 64: 777-783.
23. Zysko D, Gajek J, Rubin W, Mazurek W. Atrial fibrillation in patients with congestive heart failure and the risk of death. Folia Cardiol 2005 12: 161-167.
24. Koitabashi T, Inomata T, Niwano S, Nishii M, Takeuchi I, Nakano H et al. Paroxysmal atrial fibrillation coincident with cardiac decompensation is a predictor of poor prognosis in chronic heart failure. Circ J 2005 69: 823-830.
25. Sosin MD, Bhatia GS, Zarifis J, Davis RC, Lip GYH. An 8-year follow-up study of acute admissions with heart failure in a multiethnic population. Eur J Heart Fail 2004 6: 669-672.
26. Ahmed A, Thornton P, Perry GJ, Allman RM, DeLong JF. Impact of atrial fibrillation on mortality and readmission in older adults hospitalized with heart failure. Eur J Heart Fail 2004 6: 421-426.
27. Baldasseroni S, De Biase L, Fresco C, Marchionni N, Marini M, Masotti G et al. Cumulative effect of complete left bundle-branch block and chronic atrial fibrillation on 1-year mortality and hospitalization in patients with congestive heart failure. A report from the Italian network on congestive heart failure (in-CHF database). Eur Heart J 2002 23: 1692-1698.
28. Mahoney P, Kimmel S, DeNofrio D, Wahl P, Loh E. Prognostic significance of atrial fibrillation in patients at a tertiary medical center referred for heart transplantation because of severe heart failure. Am J Cardiol 1999 83: 1544-1547.
29. Stevenson WG, Stevenson LW, Middlekauff HR, Fonarow GC, Hamilton MA, Woo MA et al. Improving survival for patients with atrial fibrillation and advanced heart failure. J Am Coll Cardiol 1996 28: 1458-1463.
30. Takarada A, Kurogane H, Hayashi T, Fujimoto T, Yasaka Y, Fukumoto Y et al. Prognostic significance of atrial fibrillation in dilated cardiomyopathy. Jpn Heart J 1993 34: 749-758.
31. Unverferth DV, Magorien RD, Moeschberger ML, Baker PB, Fetters JK, Leier CV. Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol 1984 54: 147-152.
32. Convert G, Delaye J, Beaune J, Biron A, Gonin A. Prognosis of primary non-obstructive cardiomyopathies. Arch Mal Coeur Vaiss 1980 73: 227-237.
33. Wasywich CA, Whalley GA, Gamble GD, Wright SP, Doughty RN. Does rhythm matter? The prognostic importance of atrial fibrillation in heart failure. Heart Lung Circ 2006 15: 353-357.
34. Pedersen OD, Sondergaard P, Nielsen T, Nielsen SJ, Nielsen ES, Falstie-Jensen N et al. Atrial fibrillation, ischaemic heart disease, and the risk of death in patients with heart failure. Eur Heart J 2006 27: 2866-2870.
35. Olsson LG, Swedberg K, Ducharme A, Granger CB, Michelson EL, McMurray JJ et al. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program. J Am Coll Cardiol 2006 47: 1997-2004.
36. Swedberg K, Olsson LG, Charlesworth A, Cleland J, Hanrath P, Komajda M et al. Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET. Eur Heart J 2005 26: 1303-1308.
37. Crijns HJ, Tjeerdsma G, de Kam PJ, Boomsma F, van Gelder IC, van den Berg MP et al. Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure. Eur Heart J 2000 21: 1238-1245.
38. Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. J Am Coll Cardiol 1998 32: 695-703.
39. Carson PE, Johnson GR, Dunkman WB, Fletcher RD, Farrell L, Cohn JN. The influence of atrial fibrillation on prognosis in mild to moderate heart failure. Circulation 1993 87 (6 Suppl VI102-10.
40. Aronow WS, Ahn C, Kronzon I. Prognosis of congestive heart failure after prior myocardial infarction in older persons with atrial fibrillation versus sinus rhythm. Am J Cardiol 2001 87: 224-225.
41. Mosterd A, Cost B, Hoes AW, de Bruijne MC, Deckers JW, Hofman A et al. The prognosis of heart failure in the general population. The Rotterdam Study. Eur Heart J 2001 22: 1318-1327.
42. Carson PE, Johnson GR, Dunkman WB, Fletcher RD, Farrell L, Cohn JN. Mechanistic data from the VA cooperative studies: the influence of atrial fibrillation on prognosis in mild to moderate heart failure: the V-HeFT studies. Circulation 1993 86 (6S VI102 VI10.
43. Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 2003 107: 2920-2925.
44. Grogan M, Smith HC, Gersh BJ, Wood DL. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol 1992 69: 1570-1573.
45. Britton M, Gustafsson C. Non-rheumatic atrial fibrillation as a risk factor for stroke. Stroke 1985 16: 182-188.
46. van den Berg MP, van Gelder IC, van Veldhuisen DJ. Impact of atrial fibrillation on mortality in patients with chronic heart failure. Eur J Heart Fail 2002 4: 571-575.
47. De Ferrari GM, Klersy C, Ferrero P, Fantoni C, Salerno-Uriarte D, Manca L et al. Atrial fibrillation in heart failure patients: Prevalence in daily practice and effect on the severity of symptoms. Data from the ALPHA study registry. Eur J Heart Fail 2007 9: 502-509.
48. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee to revise the 1995 guidelines for the evaluation and management of heart failure) developed in collaboration with the International Society for Heart and Lung Transplantation endorsed by the Heart Failure Society of America 12345. J Am Coll Cardiol 2001 38: 2101-2113.
49. Rusinaru D, Leborgne L, Peltier M, Tribouilloy C. Effect of atrial fibrillation on long-term survival in patients hospitalised for heart failure with preserved ejection fraction. Eur J Heart Fail 2008 10: 566-572.
50. Benjamin EJMDS, Wolf PAMD, D'Agostino RBP, Silbershatz HP, Kannel WBMD, Levy DMD. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998 98: 946-952.
51. AFFIRM investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002 347: 1825-1833.
52. van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002 347: 1834-1840.
53. Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 2008 358: 2667-2677.
54. Wang TJ, Larson MG, Levy D, Ramachandran SV, Leip EP, Wolf PA et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 2003 17: 2920-2925.